证券记录 · 已归档季度
PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
19被追踪持有人
+1Δ持有人
24.74M持有股份
$637.46M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 -4.8% ·
净新建仓位 +5.3%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +2 | 30.81M | $780.79M | +7 | −6 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | n/a | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | n/a | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | n/a |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | n/a | 6.89M | $197.00M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 7.34M | -5.9% | $189.05M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (被动) | 5.20M | -3.9% | $133.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Renaissance Technologies ✦ | 2.14M | -10.7% | $55.10M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.94M | -13.8% | $50.05M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 5 | State Street Global Advisors ✦ (被动) | 1.90M | -2.6% | $48.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 1.31M | n/a | $33.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (被动) | 1.22M | +6.4% | $31.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 1.14M | n/a | $29.45M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 9 | JPMorgan Chase ✦ | 872.40K | n/a | $22.48M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 10 | Wellington Management ✦ | 528.51K | -3.1% | $13.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 11 | Adage Capital Partners ✦ | 410.00K | 新增 | $10.57M | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 232.99K | +118.1% | $6.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 140.40K | -1.2% | $3.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 14 | Fidelity (FMR) ✦ | 101.82K | +9.9% | $2.62M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 15 | Citadel Advisors ✦ | 71.18K | 新增 | $1.83M | 0.0% | New | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 70.76K | -86.3% | $1.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 49.98K | +4.3% | $1.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 41.79K | +17.4% | $1.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 33.33K | -20.9% | $858,991 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $10.57M | 0.0% |
| Citadel Advisors | $1.83M | 0.0% |
已清仓
| Marshall Wace | $4.55M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3 持有人, 13.02M 股份, $12.57M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 08
RIKER LAUREN
Officer · 6.00K 股 · $217,920
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 13
SC 13D/A: Doma Perpetual Capital Management LLC
Aug 07
SC 13G: STATE STREET CORP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据